Results 61 to 70 of about 28,518 (186)

A Rare Case of Pulmonary Embolism, Deep Vein Thrombosis, Bilateral Avascular Necrosis of the Femoral Head, and Miscarriage following COVID-19 in a Patient with Multiple Genetic Coagulation Factor Deficiency—A Case Report

open access: yesLife, 2023
The coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most common symptoms of COVID-19 are respiratory symptoms, but some patients develop severe thrombotic complications.
Nevena Georgieva Ivanova
doaj   +1 more source

Exploring the immunomodulatory impacts of blood manufacturing consolidation

open access: yesTransfusion, EarlyView.
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman   +11 more
wiley   +1 more source

The impact of transthoracic echocardiogram in the indication of longterm anticoagulant therapy after ischemic stroke - a Northeast Brazilian center register

open access: yesRevista Médica de Minas Gerais
Introduction: To prevent the recurrence of an ischemic stroke or transient ischemic attack (TIA), the mechanism of this event must be defined and adequate secondary prevention must be implemented.
Alan Alves de Lima Cidrão   +4 more
doaj   +1 more source

Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis [PDF]

open access: yes, 2014
BACKGROUND: Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT
Günther, A, Kwan, SKJ, Price, M
core   +1 more source

A Core Outcome Set to Guide Future Research on Caesarean Scar Ectopic Pregnancy: COSCAR Consensus Study

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 725-738, March 2026.
ABSTRACT Objective To develop a core outcome set (COS) for research on caesarean scar ectopic pregnancy (CSEP) treatment. Design Consensus development study. Setting International. Population Healthcare professionals, researchers, patient advocates, or individuals with lived experience of CSEP.
Simrit Nijjar   +11 more
wiley   +1 more source

Study on the effect of location of intracranial arterial stenosis on the safety of stenting

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2017
Objective To investigate the effect of location of intracranial arterial stenosis on the safety of intracranial stenting. Methods A total of 73 patients with symptomatic intracranial atherosclerotic stenosis (ICAS) were divided into intracranial internal
Yu-jie SUN   +4 more
doaj  

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus [PDF]

open access: yes, 2016
Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects.
Attarbaschi, Andishe   +20 more
core   +2 more sources

Low‐Molecular‐Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT‐Thromboprophylaxis Platform Trial Domain

open access: yesActa Anaesthesiologica Scandinavica, Volume 70, Issue 3, March 2026.
ABSTRACT Background Low‐molecular‐weight heparin (LMWH) is recommended for thromboprophylaxis in adult intensive care unit (ICU) patients. Despite its widespread use, there is insufficient evidence on the optimal dose, and there appears to be practice variation.
Ruben Eck   +10 more
wiley   +1 more source

Racial and socioeconomic disparities in hip fracture care [PDF]

open access: yes, 2016
BACKGROUND: Despite declines in both the incidence of and mortality following hip fracture, there are racial and socioeconomic disparities in treatment access and outcomes.
Barrett-Connor   +43 more
core   +2 more sources

Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. [PDF]

open access: yes, 2017
BACKGROUND: Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS: We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be ...
Bernstein, Richard A.   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy